iSpecimen enters ATM equity offering agreement for up to $1.5M with Rodman & Renshaw

iSpecimen Inc.

Enters At the Market Offering Agreement with Rodman & Renshaw LLC as sales agent for up to $1.5M of common stock.
Agent receives 3.0% commission on gross sales price; sales made at market prices on Nasdaq.
Agreement allows company to sell shares from time to time; no obligation to sell any shares.
Prospectus supplement filed under existing S-3 registration statement (File No. 333-265976) effective July 12, 2022.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

iSpecimen Inc. entered into At the Market Offering Agreement with Rodman & Renshaw LLC valued at $1,500,000 (effective 2024-03-05).

Action: entry
Agreement: atm program
Counterparty: Rodman & Renshaw LLC
Value: $1,500,000
Effective: 2024-03-05

Exact text from the filing

On March 5, 2024, iSpecimen Inc., a Delaware corporation (the “Company”), entered into an At the Market Offering Agreement (the “ATM Agreement”) with Rodman & Renshaw LLC as agent (the “Sales Agent”) pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share, having an aggregate offering price of up to $1,500,000 (the “Shares”), from time to time through the Sales Agent (the “Offering”).

View on SEC.gov

737 material agreements filed in the last 30 days. Browse all material agreements →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-030807

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.